• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Salesforce’s US$1.6 Billion VA AI Deal Reshaping the Investment Case for CRM?

    Simply Wall St·08/04/2026 11:30:23
    Listen to the news
    • Salesforce recently announced that the U.S. Department of Veterans Affairs awarded it a three-year Agentic Enterprise License Agreement worth up to US$1.60 billion to modernize care and service delivery with Missionforce and AI agents across its nationwide healthcare and benefits network.
    • This contract deepens Salesforce’s role in federal healthcare technology while spotlighting its Agentforce and Missionforce platforms as core tools for AI-driven workflow modernization in highly regulated public-sector environments.
    • Next, we’ll consider how this large VA AI modernization deal could reshape Salesforce’s investment narrative around agentic automation.

    We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

    Salesforce Investment Narrative Recap

    To own Salesforce, you need to believe it can turn its AI and data platforms into stickier, higher value relationships across its massive customer base. The VA’s US$1.60 billion Agentic Enterprise License Agreement reinforces that agentic automation in complex, regulated settings is a key near term catalyst, while competitive pressure from hyperscalers bundling AI and CRM remains a central risk that this deal does not fully resolve.

    Among recent announcements, the expansion with CVS Health using Agentforce Health in highly regulated healthcare settings feels closest to the VA win. Together, they underline Salesforce’s push to make Agentforce and Missionforce the backbone of AI assisted workflows in sectors where compliance, security, and reliability are non negotiable, which ties directly into the catalyst of deeper customer lock in and higher switching costs.

    Yet behind the VA win, investors should be aware of how rising data privacy and public sector compliance demands could…

    Read the full narrative on Salesforce (it's free!)

    Salesforce's narrative projects $56.7 billion revenue and $10.3 billion earnings by 2029.

    Uncover how Salesforce's forecasts yield a $241.72 fair value, a 30% upside to its current price.

    Exploring Other Perspectives

    CRM 1-Year Stock Price Chart
    CRM 1-Year Stock Price Chart

    Before the VA contract, the most bullish analysts were already assuming revenue around US$59.8 billion and earnings near US$11.7 billion by 2029, presenting a far more optimistic picture than consensus and your chosen concern about regulatory and public sector expansion risks, so this new deal may shift those narratives in very different directions.

    Explore 26 other fair value estimates on Salesforce - why the stock might be worth just $221.16!

    The Verdict Is Yours

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Seeking Other Investments?

    Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.